tyrosine has been researched along with Coronary Stenosis in 17 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (5.88) | 18.2507 |
| 2000's | 13 (76.47) | 29.6817 |
| 2010's | 3 (17.65) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Alüzüm, H; Ede, H; Erbay, AR; Erkoç, MF; Özdemir, ZT | 1 |
| Boschetti, E; D'Urbano, M; De Servi, S; Klugmann, S; La Vecchia, C; Lazzari, L; Martina, P; Morici, N; Musumeci, G; Rossini, R; Savonitto, S; Senni, M | 1 |
| Braun-Dullaeus, RC; Hass, N; Ibrahim, K; Kolschmann, S; Strasser, RH | 1 |
| Andreadou, I; Antoniadis, A; Farmakis, D; Fountoulaki, K; Ikonomidis, I; Iliodromitis, EK; Kremastinos, DT; Leftheriotis, D; Paraskevaidis, IA | 1 |
| Bongartz, LG; Braam, B; Cramer, MJ; Doevendans, PA; Gaillard, CA; Goldschmeding, R; Joles, JA; Tilburgs, C; Verhaar, MC | 1 |
| Huang, CH; Kudej, RK; Peppas, AP; Vatner, SF; Yang, G | 1 |
| Akin, Y; Biyikoglu, SF; Guray, U; Korkmaz, S; Yilmaz, MB | 1 |
| Chang, HW; Chen, CJ; Chen, MC; Chen, SM; Cheng, CI; Hung, WC; Kuo, FY; Wu, CJ; Yang, CH; Yip, HK | 1 |
| Ardissino, D; Brennan, DM; Buratti, S; Menozzi, A; Merlini, PA; Moliterno, DJ; Rossi, M; Topol, EJ | 1 |
| Barbieri, D; Ferrari, F; Ferrari, R; Guardigli, G; Parrinello, G; Percoco, G; Soukhomovskaia, O; Valgimigli, M | 1 |
| Berger, PB; Best, PJ; Chan, AW; DiBattiste, PM; Herrmann, HC; Kristensen, SD; Moliterno, DJ; Topol, EJ; White, J | 1 |
| Baum, H; Braun, S; Dibra, A; Dirschinger, J; Hadamitzky, M; Kastrati, A; Mehilli, J; Schömig, A; Schühlen, H | 1 |
| Köprülü, D; Tuhta, AG; Yeşildağ, O | 1 |
| Feldman, DN; Jayasundera, TG; Marmur, JD | 1 |
| Doggrell, SA | 1 |
| Sajid, M; Stouffer, GA | 1 |
| Banaszewski, M; Konopka, A; Stepinska, J; Szajewski, T | 1 |
2 review(s) available for tyrosine and Coronary Stenosis
| Article | Year |
|---|---|
ReoPro rules: results from the 'Do Tirofiban and ReoPro Give Similar Efficacy Trial' (TARGET).
Topics: Abciximab; Angioplasty, Balloon, Coronary; Antibodies, Monoclonal; Coronary Stenosis; Humans; Immunoglobulin Fab Fragments; Myocardial Infarction; Platelet Aggregation Inhibitors; Stents; Tirofiban; Tyrosine | 2001 |
The role of alpha(v)beta3 integrins in vascular healing.
Topics: Abciximab; Angioplasty, Balloon, Coronary; Animals; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Apoptosis; Cell Adhesion; Chemotaxis, Leukocyte; Clinical Trials as Topic; Coronary Restenosis; Coronary Stenosis; Drug Evaluation, Preclinical; Endothelium, Vascular; Eptifibatide; Humans; Immunoglobulin Fab Fragments; Models, Animal; Papio; Peptides; Platelet Adhesiveness; Rabbits; Rats; Receptors, Vitronectin; Signal Transduction; Swine; Tirofiban; Tyrosine; Vasculitis; Wound Healing | 2002 |
4 trial(s) available for tyrosine and Coronary Stenosis
| Article | Year |
|---|---|
Staccato reperfusion prevents reperfusion injury in patients undergoing coronary angioplasty: a 1-year follow-up pilot study.
Topics: Acute Coronary Syndrome; Aged; Aged, 80 and over; Angioplasty, Balloon, Coronary; Biomarkers; Coronary Stenosis; Female; Follow-Up Studies; Humans; Male; Malondialdehyde; Middle Aged; Myocardial Contraction; Myocardial Infarction; Myocardial Reperfusion; Myocardial Reperfusion Injury; Myocardium; Oxidative Stress; Pilot Projects; Recovery of Function; Secondary Prevention; Stents; Time Factors; Treatment Outcome; Tyrosine; Ultrasonography; Ventricular Function, Left | 2009 |
Thrombocytopenia caused by abciximab or tirofiban and its association with clinical outcome in patients undergoing coronary stenting.
Topics: Abciximab; Adult; Aged; Angioplasty, Balloon, Coronary; Antibodies, Monoclonal; Blood Transfusion; Combined Modality Therapy; Coronary Stenosis; Double-Blind Method; Female; Hemorrhage; Humans; Immunoglobulin Fab Fragments; Incidence; Male; Middle Aged; Myocardial Ischemia; Platelet Aggregation Inhibitors; Platelet Glycoprotein GPIIb-IIIa Complex; Prospective Studies; Risk Factors; Stents; Thrombocytopenia; Tirofiban; Treatment Outcome; Tyrosine | 2004 |
The additive value of tirofiban administered with the high-dose bolus in the prevention of ischemic complications during high-risk coronary angioplasty: the ADVANCE Trial.
Topics: Acute Disease; Aged; Angioplasty, Balloon, Coronary; Anticoagulants; Biomarkers; Coronary Stenosis; Creatine Kinase; Creatine Kinase, MB Form; Dose-Response Relationship, Drug; Double-Blind Method; Female; Heparin; Humans; Intraoperative Complications; Isoenzymes; Male; Middle Aged; Myocardial Ischemia; Platelet Aggregation Inhibitors; Prevalence; Risk Factors; Syndrome; Tirofiban; Treatment Outcome; Troponin I; Tyrosine | 2004 |
The relation of renal function to ischemic and bleeding outcomes with 2 different glycoprotein IIb/IIIa inhibitors: the do Tirofiban and ReoPro Give Similar Efficacy Outcome (TARGET) trial.
Topics: Abciximab; Aged; Aged, 80 and over; Angioplasty, Balloon, Coronary; Antibodies, Monoclonal; Coronary Stenosis; Creatinine; Female; Hemorrhage; Humans; Immunoglobulin Fab Fragments; Logistic Models; Male; Middle Aged; Myocardial Ischemia; Platelet Glycoprotein GPIIb-IIIa Complex; Renal Insufficiency; Tirofiban; Treatment Outcome; Tyrosine | 2005 |
11 other study(ies) available for tyrosine and Coronary Stenosis
| Article | Year |
|---|---|
Tirofiban induced anemia without thrombocytopenia.
Topics: Aged; Anemia; Coronary Angiography; Coronary Stenosis; Fibrinolytic Agents; Humans; Male; Stents; Thrombocytopenia; Tirofiban; Tyrosine | 2015 |
Bridge therapy or standard treatment for urgent surgery after coronary stent implantation: Analysis of 314 patients.
Topics: Ambulatory Care; Aspirin; Blood Vessel Prosthesis Implantation; Coronary Stenosis; Humans; Platelet Aggregation Inhibitors; Platelet Glycoprotein GPIIb-IIIa Complex; Postoperative Hemorrhage; Purinergic P2Y Receptor Antagonists; Retrospective Studies; Surgical Procedures, Operative; Tirofiban; Tyrosine | 2016 |
Reversible clopidogrel resistance due to right ventricular myocardial infarction: risk factor of recurrent stent thrombosis?
Topics: Angioplasty, Balloon, Coronary; Aspirin; Clopidogrel; Coronary Stenosis; Coronary Thrombosis; Drug Resistance; Drug Therapy, Combination; Drug-Eluting Stents; Electrocardiography; Enoxaparin; Fibrinolytic Agents; Humans; Male; Middle Aged; Myocardial Infarction; Platelet Aggregation Inhibitors; Recurrence; Risk Factors; Ticlopidine; Time Factors; Tirofiban; Treatment Outcome; Tyrosine; Ventricular Dysfunction, Right | 2008 |
Subtotal nephrectomy plus coronary ligation leads to more pronounced damage in both organs than either nephrectomy or coronary ligation.
Topics: Animals; Blood Pressure; Cardio-Renal Syndrome; Coronary Stenosis; Disease Models, Animal; Gene Expression; Heart Failure; Ligation; Male; Myocarditis; Nephrectomy; Nephritis; Nitrates; Nitrites; Peptidyl-Dipeptidase A; Prorenin Receptor; Rats; Rats, Inbred Lew; Receptors, Cell Surface; Renal Insufficiency, Chronic; Renin; Thiobarbituric Acid Reactive Substances; Tyrosine; Ultrasonography | 2012 |
Cardiac nerves affect myocardial stunning through reactive oxygen and nitric oxide mechanisms.
Topics: Animals; Coronary Stenosis; Denervation; Enzyme Inhibitors; Heart; Hemodynamics; Immunohistochemistry; Models, Animal; Myocardial Reperfusion; Myocardial Stunning; Myocardium; Necrosis; Nitric Oxide; Nitric Oxide Synthase; Nitroarginine; Norepinephrine; Reactive Oxygen Species; Swine; Tyrosine | 2003 |
Diffuse alveolar hemorrhage following administration of tirofiban in a patient with acute coronary syndrome: a fatal complication.
Topics: Coronary Stenosis; Fatal Outcome; Female; Hemorrhage; Humans; Lung Diseases; Middle Aged; Platelet Aggregation Inhibitors; Platelet Glycoprotein GPIIb-IIIa Complex; Tirofiban; Tyrosine | 2004 |
Transradial application of PercuSurge GuardWire device during primary percutaneous intervention of infarct-related artery with high-burden thrombus formation.
Topics: Adult; Aged; Aged, 80 and over; Angioplasty, Balloon, Coronary; Coronary Angiography; Coronary Circulation; Coronary Stenosis; Coronary Thrombosis; Coronary Vessels; Equipment Design; Female; Fibrinolytic Agents; Humans; Incidence; Intraoperative Care; Male; Middle Aged; Myocardium; Postoperative Complications; Taiwan; Tirofiban; Treatment Outcome; Tyrosine | 2004 |
Inflammatory response after intervention assessed by serial C-reactive protein measurements correlates with restenosis in patients treated with coronary stenting.
Topics: Abciximab; Aged; Angina Pectoris; Angina, Unstable; Angioplasty, Balloon, Coronary; Antibodies, Monoclonal; Anticoagulants; Aspirin; Biomarkers; C-Reactive Protein; Clopidogrel; Coronary Angiography; Coronary Restenosis; Coronary Stenosis; Female; Heparin; Humans; Immunoglobulin Fab Fragments; Inflammation; Male; Middle Aged; Postoperative Period; Premedication; Stents; Ticlopidine; Tirofiban; Tyrosine | 2005 |
Tirofiban-associated acute thrombocytopenia.
Topics: Acute Disease; Angioplasty, Balloon, Coronary; Blood Vessel Prosthesis Implantation; Coronary Stenosis; Humans; Infusions, Intravenous; Male; Middle Aged; Platelet Aggregation Inhibitors; Platelet Count; Stents; Thrombocytopenia; Tirofiban; Tyrosine | 2006 |
Tirofiban-induced coronary thrombolysis.
Topics: Angioplasty, Balloon, Coronary; Coronary Stenosis; Humans; Male; Middle Aged; Myocardial Reperfusion; Platelet Aggregation Inhibitors; Platelet Glycoprotein GPIIb-IIIa Complex; Thrombolytic Therapy; Tirofiban; Treatment Outcome; Tyrosine | 1999 |
Activated recombinant factor VII (rFVIIa) in bleeding management after therapy with IIb/IIIa-inhibitor tirofiban.
Topics: Anticoagulants; Coronary Stenosis; Drug Therapy, Combination; Enoxaparin; Factor VII; Hemorrhage; Humans; Male; Middle Aged; Platelet Aggregation Inhibitors; Platelet Glycoprotein GPIIb-IIIa Complex; Recombinant Proteins; Stents; Tirofiban; Tyrosine; Vascular Patency | 2002 |